Pierre Legault's Net Worth
$13.2 Million
Who is Pierre Legault?
Pierre Legault has an estimated net worth of $13.2 Million. This is based on reported shares across multiple companies, which include BICYCLE THERAPEUTICS plc, Syndax Pharmaceuticals Inc, RITE AID CORP, ARMO BioSciences, Inc., Urovant Sciences Ltd., Alliqua BioMedical, Inc., Cyclacel Pharmaceuticals, Inc., NPS PHARMACEUTICALS INC, FOREST LABORATORIES INC, Regado Biosciences Inc, NephroGenex, Inc., and OSI PHARMACEUTICALS INC.
SEC CIK
Pierre Legault's CIK is 0001391045
Past Insider Trading and Trends
2021 was Pierre Legault's most active year for acquiring shares with 12 total transactions. Pierre Legault's most active month to acquire stocks was the month of December. 2021 was Pierre Legault's most active year for disposing of shares, totalling 28 transactions. Pierre Legault's most active month to dispose stocks was the month of February. 2009 saw Pierre Legault paying a total of $4,971,250.00 for 181,500 shares, this is the most they've acquired in one year. In 2010 Pierre Legault cashed out on 181,500 shares for a total of $10,397,885.56, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BICYCLE THERAPEUTICS plc (BCYC) Snapshot price: $20.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +55.81% | 12K |
—
|
—
| 33.5K |
Jan 2
| |||
Form 4
| +115.00% | 11.5K |
—
|
—
| 21.5K |
Jan 3
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jan 3
| |||
Form 4
|
—
|
0
|
$33.08 | -$7,384,203.42 |
0
|
Scheduled
|
Dec 20 - Dec 22
| ||
Form 4
|
—
|
0
|
$20.23 | -$570,503.55 |
0
|
Scheduled
|
Apr 8
| ||
Form 4
|
—
|
0
|
$19.95 | -$3,602.88 |
0
|
Scheduled
|
Apr 5
| ||
Form 4
|
—
|
0
|
$19.39 | -$212,200.00 |
0
|
Scheduled
|
Mar 31
| ||
Form 4
|
—
|
0
|
$18.93 | -$156,847.60 |
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
$18.93 | -$44,630.24 |
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.42% | 17K |
—
|
—
| 65K |
Feb 7
| |||
Form 4
| +50.00% | 16K |
—
|
—
| 48K |
Feb 2
| |||
Form 4
|
—
|
0
|
$18.95 | -$615,801.60 | 32K |
Scheduled
|
Jan 12 - Jan 13
| ||
Form 4
|
—
|
0
|
$16.12 | -$331,061.60 | 32K |
Scheduled
|
Aug 5
| ||
Form 4
| +100.00% | 16K |
—
|
—
| 32K |
Feb 2
| |||
Form 4
|
—
|
0
|
$14.54 | -$617,736.40 | 16K |
Scheduled
|
Dec 20 - Dec 22
| ||
Form 4
|
∞
| 16K |
—
|
—
| 16K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RITE AID CORP (RADCQ) Snapshot price: $0.005
Senior Executive VP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.50% | -3.13K |
$1.35 | -$4,232.25 | 206.5K |
Jun 26
| |||
Form 4
| +91.21% | 100K |
—
|
—
| 209.64K |
Jun 24
| |||
Form 4
| -10.98% | -13.53K |
$2.22 | -$30,029.94 | 109.64K |
Jun 7
| |||
Form 4
| +23.17% | 23.17K |
—
|
—
| 123.17K |
Jun 26
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARMO BioSciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Urovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.48K |
—
|
—
|
0
|
Mar 29
| |||
Form 4
| +72.12% | 9K |
—
|
—
| 21.48K |
Jul 21
| |||
Form 4
|
∞
| 12.48K |
—
|
—
| 12.48K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |